Details
Stereochemistry | RACEMIC |
Molecular Formula | C12H18ClN |
Molecular Weight | 211.731 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(CC1=CC=CC=C1)NCCCCl
InChI
InChIKey=XXVROGAVTTXONC-UHFFFAOYSA-N
InChI=1S/C12H18ClN/c1-11(14-9-5-8-13)10-12-6-3-2-4-7-12/h2-4,6-7,11,14H,5,8-10H2,1H3
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/3743406Curator's Comment: description was created based on several sources, including, http://ec.europa.eu/health/documents/community-register/2000/200003093430/anx_3430_en.pdf
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3743406
Curator's Comment: description was created based on several sources, including, http://ec.europa.eu/health/documents/community-register/2000/200003093430/anx_3430_en.pdf
Mefenorex or (+/-)N-(3-chloropropyl)-1-methyl-2-phenylethylamine is an N-alkylated analogue of amphetamine. The therapeutic efficacy of mefenorex as an adjunctive support in the treatment of obesity for limited periods of time, as well as its ability to be well tolerated, has been amply demonstrated. Mefenorex is considered to be racemic mixture, no available data regarding enantiospecific pharmacological activity of the compound.
CNS Activity
Originator
Sources: http://www.google.ru/patents/DE1210873B
Curator's Comment: # Hoffmann-La Roche
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/37853
40 mg/day
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
A08AA09
Created by
admin on Fri Dec 15 17:19:58 GMT 2023 , Edited by admin on Fri Dec 15 17:19:58 GMT 2023
|
||
|
NCI_THESAURUS |
C29728
Created by
admin on Fri Dec 15 17:19:58 GMT 2023 , Edited by admin on Fri Dec 15 17:19:58 GMT 2023
|
||
|
DEA NO. |
1580
Created by
admin on Fri Dec 15 17:19:58 GMT 2023 , Edited by admin on Fri Dec 15 17:19:58 GMT 2023
|
||
|
WHO-VATC |
QA08AA09
Created by
admin on Fri Dec 15 17:19:58 GMT 2023 , Edited by admin on Fri Dec 15 17:19:58 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m7140
Created by
admin on Fri Dec 15 17:19:58 GMT 2023 , Edited by admin on Fri Dec 15 17:19:58 GMT 2023
|
PRIMARY | Merck Index | ||
|
CHEMBL2110962
Created by
admin on Fri Dec 15 17:19:58 GMT 2023 , Edited by admin on Fri Dec 15 17:19:58 GMT 2023
|
PRIMARY | |||
|
C000450
Created by
admin on Fri Dec 15 17:19:58 GMT 2023 , Edited by admin on Fri Dec 15 17:19:58 GMT 2023
|
PRIMARY | |||
|
241-279-0
Created by
admin on Fri Dec 15 17:19:58 GMT 2023 , Edited by admin on Fri Dec 15 17:19:58 GMT 2023
|
PRIMARY | |||
|
DTXSID6057665
Created by
admin on Fri Dec 15 17:19:58 GMT 2023 , Edited by admin on Fri Dec 15 17:19:58 GMT 2023
|
PRIMARY | |||
|
SUB08706MIG
Created by
admin on Fri Dec 15 17:19:58 GMT 2023 , Edited by admin on Fri Dec 15 17:19:58 GMT 2023
|
PRIMARY | |||
|
17243-57-1
Created by
admin on Fri Dec 15 17:19:58 GMT 2023 , Edited by admin on Fri Dec 15 17:19:58 GMT 2023
|
PRIMARY | |||
|
29444
Created by
admin on Fri Dec 15 17:19:58 GMT 2023 , Edited by admin on Fri Dec 15 17:19:58 GMT 2023
|
PRIMARY | RxNorm | ||
|
DB13852
Created by
admin on Fri Dec 15 17:19:58 GMT 2023 , Edited by admin on Fri Dec 15 17:19:58 GMT 2023
|
PRIMARY | |||
|
21777
Created by
admin on Fri Dec 15 17:19:58 GMT 2023 , Edited by admin on Fri Dec 15 17:19:58 GMT 2023
|
PRIMARY | |||
|
2494
Created by
admin on Fri Dec 15 17:19:58 GMT 2023 , Edited by admin on Fri Dec 15 17:19:58 GMT 2023
|
PRIMARY | |||
|
C83915
Created by
admin on Fri Dec 15 17:19:58 GMT 2023 , Edited by admin on Fri Dec 15 17:19:58 GMT 2023
|
PRIMARY | |||
|
1664
Created by
admin on Fri Dec 15 17:19:58 GMT 2023 , Edited by admin on Fri Dec 15 17:19:58 GMT 2023
|
PRIMARY | |||
|
MEFENOREX
Created by
admin on Fri Dec 15 17:19:58 GMT 2023 , Edited by admin on Fri Dec 15 17:19:58 GMT 2023
|
PRIMARY | |||
|
100000081459
Created by
admin on Fri Dec 15 17:19:58 GMT 2023 , Edited by admin on Fri Dec 15 17:19:58 GMT 2023
|
PRIMARY | |||
|
K98M4N387W
Created by
admin on Fri Dec 15 17:19:58 GMT 2023 , Edited by admin on Fri Dec 15 17:19:58 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)